and specific aims): Lipoxygenase enzymes catalyze the formation of mono-(S) hydroxy-eicosatetraenoic acids (HETE). 5-lipoxygenase (5-LO) forms a chemically complex and potent family of lipid mediators designated leukotrienes which participate in the pathophysiology of pulmonary inflammatory disorders. The current model of leukotriene production in activated cells requires redistribution of 5-lipoxygenase from a soluble, cytosolic compartment to a membrane associated state where it engages an accessory protein, 5-lipoxygenase activating protein (FLAP). Molecular process which govern the activation and redistribution of 5-LO are poorly understood. Src homology (SH) domains are conserved intra-molecular amino acid sequences which mediate protein: protein interactions that are essential features of tyrosine kinase signal transduction pathways. The application hypothesize that lipoxygenases participate in cellular signal transduction pathways via intramolecular domains that mediate protein: protein interactions. The global hypothesis is that lipoxygenase enzymes have an important and previously unrecognized role in cellular activation that is independent of their enzymatic transformation of arachidonic acid into lipid mediators.
The specific aims are to: 1) characterize protein: protein interactions between lipoxygenase enzymes and signaling proteins with SH3 domains; 2) characterize protein: protein interactions between lipoxygenase enzymes and cytoskeletal proteins; 3) characterize the effect of tyrosine kinases and mitogen-activated protein kinases on lipoxygenase enzymes; and 4) characterize 5-lipoxygenase as a GDP/GTP nucleotide exchange protein, or as a modulator of nucleotide exchange.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026730-10
Application #
2886587
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Plaut, Marshall
Project Start
1988-08-01
Project End
2001-08-31
Budget Start
1999-09-01
Budget End
2001-08-31
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Doyle, Kelly; Fitzpatrick, F A (2010) Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J Biol Chem 285:17417-24
Covey, Tracy M; Edes, Kornelia; Coombs, Gary S et al. (2010) Alkylation of the tumor suppressor PTEN activates Akt and ýý-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer. PLoS One 5:e13545
Cassidy, Pamela B; Edes, Kornelia; Nelson, Chad C et al. (2006) Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 27:2538-49
Wagner, Tracy M; Mullally, James E; Fitzpatrick, F A (2006) Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translati J Biol Chem 281:2598-604
Fitzpatrick, F A (2004) Cyclooxygenase enzymes: regulation and function. Curr Pharm Des 10:577-88
Yu, Margaret K; Moos, Philip J; Cassidy, Pamela et al. (2004) Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase: modulation of selenoproteins by lipoxygenase enzymes. J Biol Chem 279:28028-35
Verbitski, Sheryl M; Mullally, James E; Fitzpatrick, Frank A et al. (2004) Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity. J Med Chem 47:2062-70
Moos, Philip J; Edes, Kornelia; Mullally, James E et al. (2004) Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 25:1611-7
Moos, Philip J; Edes, Kornelia; Cassidy, Pamela et al. (2003) Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J Biol Chem 278:745-50
Fitzpatrick, F A; Wheeler, Richard (2003) The immunopharmacology of paclitaxel (Taxol), docetaxel (Taxotere), and related agents. Int Immunopharmacol 3:1699-714

Showing the most recent 10 out of 29 publications